Kaya Özge, Keskinkaya Z, Işık Mermutlu S, Oğuz Kılıç S, Öztürk S. Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?. Dermatol Pract Concept [Internet]. 2023 Jul. 31 [cited 2026 Apr. 22];13(3):e2023145. Available from: https://dpcj.org/index.php/dpc/article/view/2912